Avg closing price
Price range

4 David Einhorn NeuBase Therapeutics Trades

David Einhorn's position in NeuBase Therapeutics is currently worth $3.19 Million. That's 0.26% of their equity portfolio (34th largest holding). The investor owns 7.73% of the outstanding NeuBase Therapeutics stock. David Einhorn acquired their 2.73 Million shares between 2019 and 2021. So far they never sold any shares in the company. The investor's estimated purchase price is $15.5 Million, resulting in a loss of 79%.

Avg closing price
Price range
Increased shares by 34.5% (+700 Thousand shares) Q2 2021
Avg closing price $5.52
Price range $4.63 - $7.34
Increased shares by 6.5% (+124 Thousand shares) Q3 2020
Avg closing price $8.16
Price range $7.25 - $9.71
Increased shares by 23.7% (+365 Thousand shares) Q2 2020
Avg closing price $8.37
Price range $6.69 - $11.51
New holding (+1.54 Million shares) Q3 2019
Avg closing price $4.94
Price range $3.15 - $6.59

News about NeuBase Therapeutics Inc and David Einhorn

Embed chart

Easily embed the chart on your blog or website – it will always update automatically!